Ianalumab (VAY736) in primary Sjögren's syndrome: assessing disease activity using multi-modal ultrasound

To apply serial ultrasound (US) assessments to show effects of ianalumab (anti-BAFF-R monoclonal antibody) on inflamed salivary glands of patients with primary Sjögren's syndrome (pSS). In a single-centre, 24-week double-blind study (NCT02149420), 27 pSS patients of moderate-to-severe activity...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical and experimental rheumatology 2020-07, Vol.38 Suppl 126 (4), p.228-236
Hauptverfasser:	Diekhoff, Torsten, Fischer, Thomas, Schefer, Quirino, Posch, Maximilian Georg, Dörner, Thomas, Laurent, Didier, Li, Yue, Wagner, Frank D, Oliver, Stephen John
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized - therapeutic use Humans Parotid Gland - diagnostic imaging Salivary Glands - diagnostic imaging Sjogren's Syndrome - diagnostic imaging Sjogren's Syndrome - drug therapy Submandibular Gland - diagnostic imaging Ultrasonography
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!